dermatological conditions

Almirall partners with Ablexis and AlivaMab Discovery Services to accelerate its development efforts for innovative treatment options for patients suffering from severe skin diseases

Through this license agreement with Ablexis, Almirall is granted rights to use the AlivaMab® Mouse technology for research, development, and…

2 years ago

Almirall’s open innovation platform AlmirallShare announces two new partnerships aimed at finding new ways for the treatment of skin cancer and atopic dermatitis

These collaborations are in response to the calls for innovation via AlmirallShare, the open innovation platform of Almirall and aim…

3 years ago